Drugmakers to Submit Clinical Trial Data on Failed Products Under New Proposed Rule

Drug Industry Daily
A A
Drug and biologic makers would have to submit all clinical trial data to the federal government — including data for products not approved by the FDA — under a massive proposed expansion of data collection.

To View This Article:

Login

Subscribe To Drug Industry Daily